AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

被引：0
|
作者：
Gul, A. [1 ]
Kurtuncu, M. [1 ]
Erdugan, M. [1 ]
Oguz, E. [1 ]
Gunduz, T. [1 ]
Demir, G. Akman [1 ]
Sevgi, S. [2 ]
Turgay, S. [2 ]
Acar, E. [2 ]
机构：
[1] Istanbul Fac Med, Istanbul, Turkey
[2] Novartis Turkey, Istanbul, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0480
引用
收藏
页码：1533 / 1534
页数：2
相关论文
共 50 条
  • [31] INTERIM LONG-TERM SAFETY/EFFICACY OF RISANKIZUMAB TREATMENT IN CROHN'S DISEASE PATIENTS FROM THE OPEN-LABEL EXTENSION STUDY
    Ferrante, M.
    Panes, J.
    Baert, F.
    Louis, E.
    Kaser, A.
    Gustafson, D.
    Hall, D.
    Boecher, W. O.
    Herichova, I.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G.
    GUT, 2019, 68 : A64 - A64
  • [32] EPOPEX, EFFICACY AND SAFETY OF EPICUTANEOUS IMMUNOTHERAPY IN PEANUT-ALLERGIC TODDLERS: 1-YEAR OPEN-LABEL EXTENSION TO EPITOPE
    Greenhawt, M.
    Wang, J.
    DuToit, G.
    O'Sullivan, M.
    Brown-Whitehorn, T.
    Bois, T.
    Bahnson, H.
    Rouissi, R.
    Bee, K.
    Green, T.
    Campbell, D.
    Sampson, H.
    Burks, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S231 - S231
  • [33] Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease -: An open-label trial
    Tugal-Tutkun, I
    Mudun, A
    Urgancioglu, M
    Kamali, S
    Kasapoglu, E
    Inanc, M
    Gül, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2478 - 2484
  • [34] Efficacy and safety of rifaximin in the treatment of mild-moderate Crohn's disease: Results of an open-label pilot study
    Kornbluth, A
    Hunt, M
    George, J
    Latzman, G
    Rochester, J
    Fried-Boxt, E
    Legnani, P
    GASTROENTEROLOGY, 2005, 128 (04) : A579 - A579
  • [35] An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression
    DeKarske, Daryl
    Alva, Gustavo
    Aldred, Jason L.
    Coate, Bruce
    Cantillon, Marc
    Jacobi, Lori
    Nunez, Rene
    Norton, James C.
    Abler, Victor
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1751 - 1761
  • [36] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [37] Remission and clinical response induced and maintained in patients with active Crohn's disease treated for 1-year open-label with adalimumab
    Sandborn, WJ
    Hanauer, SB
    Lukas, M
    Wolf, DC
    Isaacs, KL
    MacIntosh, DG
    Panaccione, R
    Rutgeerts, P
    Pollack, PF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S316 - S317
  • [38] A 21-month open-label study of the safety and efficacy of Alzhemed™ in patients with Alzheimer's disease:: preliminary results
    Vellas, B
    Aisen, R
    Mehran, M
    Poole, R
    Lavoie, I
    Gervais, F
    Laurin, J
    Briand, R
    Garceau, D
    JOURNAL OF NEUROLOGY, 2004, 251 : 39 - 39
  • [39] Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study
    Nakamura, Yu
    Omori, Takumi
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 685 - 693
  • [40] Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
    Iwata, Naomi
    Nishimura, Kenichi
    Hara, Ryoki
    Imagawa, Tomoyuki
    Shimizu, Masaki
    Tomiita, Minako
    Umebayashi, Hiroaki
    Takei, Syuji
    Seko, Noriko
    Wakabayashi, Ryota
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2023, 33 (06) : 1162 - 1170
12345